Related Experiment Video
Updated: Feb 27, 2026

Interventional Diagnostic Procedure: A Practical Guide for the Assessment of Coronary Vascular Function
Published on: March 15, 2022
Percutaneous coronary intervention in left main coronary artery disease with or without intravascular ultrasound: A
Yicong Ye1, Ming Yang1, Shuyang Zhang1
1Department of Cardiology, Peking Union Medical College Hospital, Peking Union Medical College & Chinese Academy of Medical Sciences, Beijing, China.
Insights
Intravascular ultrasound (IVUS)-guided percutaneous coronary intervention (PCI) significantly reduces mortality in left main coronary artery disease (LM CAD) patients compared to angiography-guided PCI. This meta-analysis confirms IVUS guidance improves outcomes, lowering risks of death and complications.
Area of Science:
- Cardiovascular Medicine
- Interventional Cardiology
- Medical Imaging
Background:
- Current guidelines suggest intravascular ultrasound (IVUS) guidance for percutaneous coronary intervention (PCI) in left main coronary artery disease (LM CAD).
- Evidence comparing IVUS-guided versus angiography-guided PCI in LM CAD requires comprehensive synthesis.
Purpose of the Study:
- To compare the effectiveness of IVUS-guided PCI versus angiography-guided PCI in patients with LM CAD.
- To evaluate the impact of IVUS guidance on mortality and other adverse events in LM CAD patients.
Main Methods:
- Systematic literature search of MEDLINE, Embase, and Cochrane Central Register of Controlled Trials.
- Inclusion of 10 studies (1 randomized, 9 non-randomized) with 6,480 patients comparing IVUS-guided with angiography-guided PCI in LM CAD.
- Primary outcome assessed was mortality (all-cause and cardiac death).
Main Results:
- IVUS-guided PCI was associated with significantly lower risks of all-cause death (RR 0.60) and cardiac death (RR 0.47) compared to angiography-guided PCI.
- Reduced risks observed for target lesion revascularization (RR 0.43) and in-stent thrombosis (RR 0.28) with IVUS guidance.
- Beneficial effects of IVUS-guided PCI were consistent across study types, populations, and follow-up durations.
Conclusions:
- IVUS-guided PCI significantly reduces all-cause mortality by approximately 40% in patients with LM CAD compared to conventional angiography guidance.
- IVUS guidance is associated with improved safety outcomes, including reduced cardiac death, revascularization, and in-stent thrombosis.
- The findings support the use of IVUS guidance in LM CAD interventions.
Abstract:
This meta-analysis compared IVUS-guided with angiography-guided PCI to determine the effect of IVUS on the mortality in patients with LM CAD. Current guidelines recommend intravascular ultrasound (IVUS)-guided percutaneous coronary intervention (PCI) in patients with left main coronary artery disease (LM CAD; Class IIa, level of evidence B). A systematic search of the MEDLINE, Embase, and Cochrane Central Register of Controlled Trials databases was conducted to identify randomized or non-randomized studies comparing IVUS-guided PCI with angiography-guided PCI in LM CAD. Ten studies (9 non-randomized and 1 randomized) with 6,480 patients were included. The primary outcome was mortality including all-cause death and cardiac death. Compared with angiography-guide PCI, IVUS-guided PCI was associated with significantly lower risks of all-cause death (risk ratio [RR] 0.60, 95% confidence interval [CI] 0.47-0.75, p<0.001), cardiac death (RR 0.47, 95% CI 0.33-0.66, p<0.001), target lesion revascularization (RR 0.43, 95% CI 0.25-0.73, p = 0.002), and in-stent thrombosis (RR 0.28, 95% CI 0.12-0.67, p = 0.004). Subgroup analyses indicated the beneficial effect of IVUS-guide PCI was consistent across different types of studies (unadjusted non-randomized studies, propensity score-matched non-randomized studies, or randomized trial), study populations (Asian versus non-Asian), and lengths of follow-up (<3 years versus ≥3 years). IVUS-guided PCI in LM CAD significantly reduced the risks of all-cause death by ~40% compared with conventional angiography-guided PCI. PROSPERO registration number: CRD 42017055134.
More Related Videos
13:48Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
Published on: April 21, 2023
13:10Direct Re-implantation of Left Coronary Artery into the Aorta in Adults with Anomalous Origin of Left Coronary Artery from the Pulmonary Artery ALCAPA
Published on: April 24, 2017
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Cardiac Catheterization III: Left Heart Catheterization
Acute Coronary Syndrome IV: Interprofessional Care
Coronary Artery Disease V: Interprofessional Care
Coronary Artery Disease I: Introduction